Volatility Is Bottoming
| VXZ Etf | USD 48.02 0.20 0.42% |
Slightly above 54% of IPath Series' investor base is interested to short. The current sentiment regarding investing in iPath Series B etf implies that many traders are impartial. IPath Series' investing sentiment can be driven by a variety of factors including economic data, IPath Series' earnings reports, geopolitical events, and overall market trends.
IPath |
Selling with such an increase in volume has previously preceded an increase in volatility.
Read at talkmarkets.com
 |
IPath Series Fundamental Analysis
We analyze IPath Series' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IPath Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IPath Series based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
IPath Series is currently under evaluation in net asset as compared to similar ETFs. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
iPath Series B Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IPath Series etf to make a market-neutral strategy. Peer analysis of IPath Series could also be used in its relative valuation, which is a method of valuing IPath Series by comparing valuation metrics with similar companies.
Peers
IPath Series Related Equities
| SVXY | ProShares Short | 0.15 | ||||
| RWM | ProShares Short | 0.06 | ||||
| VXX | IPath Series | 0.37 | ||||
| VIXY | ProShares VIX | 0.44 | ||||
| VIXM | ProShares VIX | 1.78 |
Check out IPath Series Hype Analysis, IPath Series Correlation and IPath Series Performance. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
The market value of iPath Series B is measured differently than its book value, which is the value of IPath that is recorded on the company's balance sheet. Investors also form their own opinion of IPath Series' value that differs from its market value or its book value, called intrinsic value, which is IPath Series' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IPath Series' market value can be influenced by many factors that don't directly affect IPath Series' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IPath Series' value and its price as these two are different measures arrived at by different means. Investors typically determine if IPath Series is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IPath Series' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.